42 studies found for:    vedolizumab
Show Display Options
Rank Status Study
1 Not yet recruiting Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
Conditions: Colitis, Ulcerative;   Crohn Disease
Intervention: Drug: Vedolizumab
2 Completed Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration
Condition: Healthy
Interventions: Drug: Vedolizumab SC;   Drug: Vedolizumab IV
3 Completed
Has Results
Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Vedolizumab;   Drug: Placebo
4 Not yet recruiting Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab;   Drug: Ciprofloxacin;   Drug: Vedolizumab Placebo
5 Recruiting Dose Finding Study of Vedolizumab for Graft-Versus-Host Disease (GvHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Condition: Allogeneic Hematopoietic Stem Cell Transplantation
Intervention: Drug: Vedolizumab
6 Recruiting Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Vedolizumab;   Drug: Placebo
7 Completed
Has Results
Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
Conditions: Ulcerative Colitis;   Crohn's Disease
Intervention: Drug: vedolizumab
8 Recruiting Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Vedolizumab;   Drug: Vedolizumab placebo
9 Active, not recruiting Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Vedolizumab;   Drug: Vedolizumab placebo
10 Not yet recruiting Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Vedolizumab
11 Not yet recruiting Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
Conditions: Colitis, Ulcerative;   Crohn Disease
Intervention: Drug: Vedolizumab
12 Completed
Has Results
Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
Condition: Inflammatory Bowel Disease
Interventions: Drug: Vedolizumab;   Drug: Placebo;   Biological: Hepatitis B vaccine;   Biological: Oral cholera vaccine
13 Recruiting Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab IV 300 mg;   Drug: Placebo IV;   Drug: Vedolizumab SC 108 mg;   Drug: Placebo SC
14 Completed
Has Results
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: vedolizumab;   Other: Placebo
15 Completed
Has Results
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: vedolizumab;   Other: Placebo
16 Recruiting An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab;   Drug: Adalimumab placebo;   Drug: Adalimumab;   Drug: Vedolizumab placebo
17 Completed
Has Results
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: vedolizumab;   Other: Placebo
18 Not yet recruiting Vedolizumab Subcutaneous Long-Term Open-Label Extension Study
Conditions: Colitis, Ulcerative;   Crohn Disease
Intervention: Drug: Vedolizumab SC
19 Recruiting Corticosteroids With Vedolizumab in Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Prednisone;   Drug: Placebo;   Drug: Vedolizumab
20 Recruiting OTIS Vedolizumab Pregnancy Exposure Registry
Conditions: Colitis, Ulcerative;   Crohn's Disease
Interventions: Drug: Vedolizumab;   Biological: Other Biological Agent

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years